Skip to main content

Search

15 result(s) for 'author#Laura M Heiser' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Authors: Zhi Hu, Jian-Hua Mao, Christina Curtis, Ge Huang, Shenda Gu, Laura Heiser, Marc E. Lenburg, James E. Korkola, Nora Bayani, Shamith Samarajiwa, Jose A. Seoane, Mark A. Dane, Amanda Esch, Heidi S. Feiler, Nicholas J. Wang, Mary Ann Hardwicke…
    Citation: Breast Cancer Research 2017 19:17

    The original article was published in Breast Cancer Research 2016 18:70

  2. Although there is good evidence to support the effectiveness of cognitive behavioral therapy (CBT) for the outpatient treatment of adolescent major depressive disorder (MDD), evidence-based manuals for the inp...

    Authors: Michael Frey, Kathrin Pietsch, Laura Weninger, Matthias Brockhaus, Fabian Loy, Nathalie Claus, Petra Wagenbüchler, Selina Kornbichler, Jana Kroboth, Beatrice Georgii, Inga Wermuth, Anna Kititsina, Katharina Heiser, Gerd Schulte-Körne and Belinda Platt
    Citation: Pilot and Feasibility Studies 2020 6:30
  3. During the type-setting of the final version of the article [1] some of the additional files were swapped. The correct files are republished in this Erratum.

    Authors: Anneleen Daemen, Obi L Griffith, Laura M Heiser, Nicholas J Wang, Oana M Enache, Zachary Sanborn, Francois Pepin, Steffen Durinck, James E Korkola, Malachi Griffith, Joe S Hur, Nam Huh, Jongsuk Chung, Leslie Cope, Mary Jo Fackler, Christopher Umbricht…
    Citation: Genome Biology 2015 16:95

    The original article was published in Genome Biology 2013 14:R110

  4. We have developed a new protocol for using molecular inversion probes to accurately and specifically measure allele copy number. The new protocol provides for significant improvements, including the reduction ...

    Authors: Yuker Wang, Martin Moorhead, George Karlin-Neumann, Nicholas J Wang, James Ireland, Steven Lin, Chunnuan Chen, Laura M Heiser, Koei Chin, Laura Esserman, Joe W Gray, Paul T Spellman and Malek Faham
    Citation: Genome Biology 2007 8:R246
  5. First-generation molecular profiles for human breast cancers have enabled the identification of features that can predict therapeutic response; however, little is known about how the various data types can bes...

    Authors: Anneleen Daemen, Obi L Griffith, Laura M Heiser, Nicholas J Wang, Oana M Enache, Zachary Sanborn, Francois Pepin, Steffen Durinck, James E Korkola, Malachi Griffith, Joe S Hur, Nam Huh, Jongsuk Chung, Leslie Cope, Mary Jo Fackler, Christopher Umbricht…
    Citation: Genome Biology 2013 14:R110

    The Erratum to this article has been published in Genome Biology 2015 16:95

  6. In biological experiments, comprehensive experimental metadata tracking – which comprises experiment, reagent, and protocol annotation with controlled vocabulary from established ontologies – remains a challen...

    Authors: Elmar Bucher, Cheryl J. Claunch, Derrick Hee, Rebecca L. Smith, Kaylyn Devlin, Wallace Thompson, James E. Korkola and Laura M. Heiser
    Citation: BMC Bioinformatics 2019 20:542
  7. The Resident Assessment Instrument-Minimum Data Set (RAI-MDS) 2.0 is designed to collect the minimum amount of data to guide care planning and monitoring for residents in long-term care settings. These data ha...

    Authors: Alison M Hutchinson, Doris L Milke, Suzanne Maisey, Cynthia Johnson, Janet E Squires, Gary Teare and Carole A Estabrooks
    Citation: BMC Health Services Research 2010 10:166
  8. Cancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-...

    Authors: Laura M Heiser, Nicholas J Wang, Carolyn L Talcott, Keith R Laderoute, Merrill Knapp, Yinghui Guan, Zhi Hu, Safiyyah Ziyad, Barbara L Weber, Sylvie Laquerre, Jeffrey R Jackson, Richard F Wooster, Wen Lin Kuo, Joe W Gray and Paul T Spellman
    Citation: Genome Biology 2009 10:R31
  9. Systemic chemotherapy in the adjuvant setting can cure breast cancer in some patients that would otherwise recur with incurable, metastatic disease. However, since only a fraction of patients would have recurr...

    Authors: Obi L Griffith, François Pepin, Oana M Enache, Laura M Heiser, Eric A Collisson, Paul T Spellman and Joe W Gray
    Citation: Genome Medicine 2013 5:92
  10. Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive type of cancer that lacks effective targeted therapy. Despite detailed molecular profiling, no targeted therapy has been establishe...

    Authors: Prson Gautam, Leena Karhinen, Agnieszka Szwajda, Sawan Kumar Jha, Bhagwan Yadav, Tero Aittokallio and Krister Wennerberg
    Citation: Molecular Cancer 2016 15:34
  11. Polyamines regulate important cellular functions and polyamine dysregulation frequently occurs in cancer. The objective of this study was to use a systems approach to study the relative effects of PG-11047, a ...

    Authors: Wen-Lin Kuo, Debopriya Das, Safiyyah Ziyad, Sanchita Bhattacharya, William J Gibb, Laura M Heiser, Anguraj Sadanandam, Gerald V Fontenay, Zhi Hu, Nicholas J Wang, Nora Bayani, Heidi S Feiler, Richard M Neve, Andrew J Wyrobek, Paul T Spellman, Laurence J Marton…
    Citation: BMC Medicine 2009 7:77
  12. Activation of the phosphatidylinositol 3-kinase (PI3K) pathway in estrogen receptor α (ER)-positive breast cancer is associated with reduced ER expression and activity, luminal B subtype, and poor outcome. Pho...

    Authors: Xiaoyong Fu, Chad J Creighton, Nrusingh C Biswal, Vijetha Kumar, Martin Shea, Sabrina Herrera, Alejandro Contreras, Carolina Gutierrez, Tao Wang, Sarmistha Nanda, Mario Giuliano, Gladys Morrison, Agostina Nardone, Kristen L Karlin, Thomas F Westbrook, Laura M Heiser…
    Citation: Breast Cancer Research 2014 16:430
  13. HER2-amplified breast cancer is a clinically defined subtype of breast cancer for which there are multiple viable targeted therapies. Resistance to these targeted therapies is a common problem, but the mechanisms...

    Authors: Joseph P. Garay, Rebecca Smith, Kaylyn Devlin, Daniel P. Hollern, Tiera Liby, Moqing Liu, Shanta Boddapati, Spencer S. Watson, Amanda Esch, Ting Zheng, Wallace Thompson, Darcie Babcock, Sunjong Kwon, Koei Chin, Laura Heiser, Joe W. Gray…
    Citation: Breast Cancer Research 2021 23:81
  14. High mitotic activity is associated with the genesis and progression of many cancers. Small molecule inhibitors of mitotic apparatus proteins are now being developed and evaluated clinically as anticancer agen...

    Authors: Zhi Hu, Jian-Hua Mao, Christina Curtis, Ge Huang, Shenda Gu, Laura Heiser, Marc E. Lenburg, James E. Korkola, Nora Bayani, Shamith Samarajiwa, Jose A. Seoane, Mark A. Dane, Amanda Esch, Heidi S. Feiler, Nicholas J. Wang, Mary Ann Hardwicke…
    Citation: Breast Cancer Research 2016 18:70

    The Erratum to this article has been published in Breast Cancer Research 2017 19:17

  15. The growth factor receptor network (GFRN) plays a significant role in driving key oncogenic processes. However, assessment of global GFRN activity is challenging due to complex crosstalk among GFRN components,...

    Authors: Mumtahena Rahman, Shelley M. MacNeil, David F. Jenkins, Gajendra Shrestha, Sydney R. Wyatt, Jasmine A. McQuerry, Stephen R. Piccolo, Laura M. Heiser, Joe W. Gray, W. Evan Johnson and Andrea H. Bild
    Citation: Genome Medicine 2017 9:40